{"abstract": "The drug giant reported that third-quarter product sales in China, where it faces a continuing bribery investigation, dropped 61 percent as rivals grabbed market share.", "web_url": "https://www.nytimes.com/2013/10/24/business/international/glaxosmithkline-earnings-hit-by-slumping-china-sales.html", "snippet": "The drug giant reported that third-quarter product sales in China, where it faces a continuing bribery investigation, dropped 61 percent as rivals grabbed market share.", "lead_paragraph": "The drug maker GlaxoSmithKline reported Wednesday that its third-quarter earnings were badly battered by slumping product sales in China, a country where it faces a continuing bribery investigation.", "print_section": "B", "print_page": "2", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "xlarge", "caption": null, "credit": null, "type": "image", "url": "images/2013/10/24/business/Glaxo/Glaxo-articleLarge.jpg", "height": 820, "width": 600, "subType": "xlarge", "crop_name": "articleLarge", "legacy": {"xlarge": "images/2013/10/24/business/Glaxo/Glaxo-articleLarge.jpg", "xlargewidth": 600, "xlargeheight": 820}}, {"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2013/10/24/business/Glaxo/Glaxo-jumbo.jpg", "height": 1024, "width": 750, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2013/10/24/business/Glaxo/Glaxo-superJumbo.jpg", "height": 1950, "width": 1427, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2013/10/24/business/Glaxo/Glaxo-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2013/10/24/business/Glaxo/Glaxo-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2013/10/24/business/Glaxo/Glaxo-thumbLarge.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": "Glaxo Sales Fall in China as Inquiry Continues", "kicker": null, "content_kicker": null, "print_headline": "Glaxo Sales Fall in China As Inquiry Continues", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Company Reports", "rank": 2, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 3, "major": "N"}, {"name": "organizations", "value": "GlaxoSmithKline PLC", "rank": 4, "major": "N"}, {"name": "subject", "value": "Bribery and Kickbacks", "rank": 5, "major": "N"}, {"name": "glocations", "value": "China", "rank": 6, "major": "N"}], "pub_date": "2013-10-23T18:32:41+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "subsection_name": "International Business", "byline": {"original": "By Barry Meier", "person": [{"firstname": "Barry", "middlename": null, "lastname": "Meier", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/956abe66-395d-5659-a08b-3172ff17fd71", "word_count": 536, "uri": "nyt://article/956abe66-395d-5659-a08b-3172ff17fd71"}